Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chemokine C-X-C motif receptor 1 (CXCR1) is a G protein-coupled receptor principally expressed on neutrophils and other immune cells, serving as a high-affinity receptor for the chemokine CXCL8 (also known as interleukin-8)[2][3]. Activation of CXCR1 by CXCL8 initiates intracellular signaling that promotes chemotaxis, degranulation, and other neutrophil effector functions crucial for innate immune response and inflammation[2]. CXCR1, along with the closely related CXCR2, is implicated in mediating inflammatory responses and plays a notable role in several pathological conditions, including cancer progression, infections, and chronic inflammatory diseases[2]. The receptor is a validated therapeutic target with several inhibitors studied for inflammatory and oncologic indications, though its central role in neutrophil function raises potential safety concerns regarding infection susceptibility[2][3].
Antagonism of receptor-mediated chemokine signaling; Blockage of G protein signaling cascade; Inhibition of neutrophil migration and activation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chemokine C-X-C motif receptor 1 (CXCR1).